Skip to main content
. Author manuscript; available in PMC: 2019 Jan 4.
Published in final edited form as: Cancer Drug Resist. 2018 Mar 19;1:48–58. doi: 10.20517/cdr.2018.01

Figure 5:

Figure 5:

Caspase-3/7 activity rescue data. HCT116 p53+/+ and HCT116 p53−/− cells were co-treated with indicated concentrations of (left) F10 or (right) 5-FU along with indicated nucleoside (uridine = 1 mmol/L, thymidine = 80 μmol/L) for 48 h. Caspase activity per cell viability was determined using Promega’s Caspase-Glo assay after 48 h and calculated following blank subtraction relative to respective control activity. Experiments done in triplicate ± SEM. P-values calculated using GraphPad Prism (n = 4; ****P ≤ 0.0001)